Insulin-like growth factors (IGF) I and II are polypeptides with both growth-promoting and insulin-like metabolic effects. The developmentally specific expression of IGF I and II in the nervous system implies a role for these growth factors in neuronal growth and differentiation. In the present study, we analyzed IGF and IGF receptor mRNA transcripts from two related human neuroblastoma cell lines, SH-SY5Y and SK-N-SH. These cell lines provide a good in vitro model of neuronal development. Northern analysis of total RNA from each cell line revealed three IGF II mRNA transcripts (6.0, 4.8, and 1.8 kb), and one mRNA transcript each for the type I (11.0 kb) and type II (9.4 kb) IGF receptors. The size distribution of these multiple transcripts is similar to that found during normal human fetal development. These results establish both cell lines as good in vitro models for investigating the mechanisms which underly IGF gene expression during nervous system development.
INTRODUCTION
Insulin-like growth factors 1 and II (IGF I and IGF II) belong to a family of polypeptides with growth promoting and insulin-like metabolic activity 10, 33 . Gene expression of IGF I and II is differentially regulated during development 8. IGF mRNAs are present in a wide variety of size classes, depending on the developmental stage and tissue source of the transcripts. In human fetal brain, the primary IGF I mRNA species are 4.4 and 7.5 kb 31. In adult human brain, expression of IGF I mRNA is negligible or absent 8'33, however, a 7.0-7.5 kb IGF I mRNA is present in adult rat brain 9. Transcription of the IGF II gene is initiated at one of four promotor sites, leading to mRNAs with similar coding but different 5' untranslated regions 13. A 6.0 kb IGF II mRNA is abundantly expressed in fetal tissues with lesser expression in the adult, where a 4.8 kb mRNA likely represents the major adult IGF II transcript 5,6,~1,33.
As an initial approach toward understanding the regulation of developmentally specific IGF mRNA transcripts in the nervous system, we characterized the different IGF mRNA transcripts in two human neuroblastoma cell lines, SH-SY5Y and its parent line, SK-N-SH. These cell lines were chosen as neuronal models of IGF gene regulation and function for two reasons. First, both cell lines undergo phenotypic changes from mitogenically active to differentiated neurons, thereby providing in vitro models of normal neuronal development 23'24. Secondly, these phenotypic changes can be affected by IGFs t2'26'27'28. We therefore speculated that mitogenically active SH-SY5Y and SK-N-SH cells would have the same IGF and 1GF receptor transcripts as fetal neuronal tissue.
In the current study, we have characterized all IGF and IGF receptor mRNA transcripts present in actively dividing SH-SY5Y and SK-N-SH cells. We report that the distribution of these transcript sizes in mitogenic cells is similar to that found in the developing nervous system. Our results in mitogenic neurons can serve as a basis for future comparisons between the IGF and IGF receptor mRNA transcripts present in dividing and differentiated neuronal phenotypes. 
MATERIALS AND METHODS

Materials
Northern analysis
Northern analysis was performed as previously described l~>. Briefly, total cellular RNA was isolated from SH-SY5Y and SK-N-SH cells using guanidinium thiocyanate-phenol extraction 3. RNA samples (20/xg) and 5 gg 0.24-9.5 kb RNA ladder (Bethesda Research Laboratories) were electrophoresed in denaturing gels containing 1% agarose, 2.2 M formaldehyde, 0.02 M MOPS (3-[N-morpholino] propane-sulfonic acid), 1 mM EDTA, and 5 mM sodium acetate. Nytran membranes (Schleicher and Schuell, Keene, NH) were hybridized with high specific activity (2-90x107 cpm//zg) cDNA probes for 12-16 h at 42°C. Membranes were exposed to autoradiographic film (Eastman Kodak Co., NY) in the presence of intensifying screens at -70°C for 1-7 days.
RNase protection assay
RNase protection was performed as previously described 1~. RNA samples (10-50 ~zg) were hybridized overnight at 50°C with 5 x 104 cpm IGF I1 riboprobe, then digested with 40 /zg/ml RNase A (Sigma). Samples were extracted with phenol, precipitated and resuspended in 5 /zt of 80% formamide loading buffer, then electrophoresed on 6% polyacrylamide, 8 M urea sequencing gels. Gels were then dried and exposed to autoradiographic film using an intensifying screen at -70°C for 1-3 days.
RESULTS
IGF gene expression
Using Northern analysis of total RNA isolated from SH-SY5Y and SK-N-SH cell lines, we found that an 854 bp IGF II cDNA hybridized with 1.8, 4.8 and 6.0 kb RNA transcripts from both cell lines (Fig. 1A,B) . By RNase protection analysis of total RNA from both cell lines, we found a 580 bp fragment of the 854-bp IGF II probe was protected from RNase degradation. (Fig.  1C) . No specific hybridization between the 818 bp IGF I cDNA and total RNA from SH-SY5Y or SK-N-SH cells in Northern analysis experiments was detected ( Fig. 2A,B) . In the same experiments, we detected multiple IGF I mRNA transcripts of 7.8, !.6-2.1, and 0.8-1.2 kb by Northern hybridization of the 818 bp IGF I cDNA with rat liver total RNA ( Fig. 2A,B) . This result is consistent with previously reported IGF I transcript sizes in rat liver 34.
IGF receptor gene expression
By Northern analysis with the 1247 bp type I IGF receptor eDNA of total RNA from SH-SY5Y or SK-N-SH cells, we detected one 11 kb RNA transcript (Fig.  3A, B) . Using Northern analysis with the 9.1 kb type II IGF receptor cDNA, we detected one 9.4 kb RNA transcript in total RNA from SH-SY5Y and SK-N-SH cells (Fig. 4A,B) .
DISCUSSION
Multiple class sizes of IGF I and IGF II mRNAs are expressed in a tissue and time specific manner. In human fetal brain, the major IGF I mRNA species are 7.5 and 4.4 kb, while 1.6 and 2.5 kb IGF ! mRNA transcripts are present in the adult 3t. Transcription of the human IGF II gene is under the control of multiple promoters 13. In human fetal tissue, the P3 promoter is active, giving rise to abundant 6.0 kb IGF II mRNAs. Initiation of transcription of the P4 promoter predominates in the adult, producing lower total amounts of IGF II mRNA and a major 4.8 kb transcript 5'6.
The developmentally specific expression of multiple IGF mRNA species in the nervous system implies a role for IGFs in neuronal growth and maturation. We have used two neuroblastoma cell lines, SK-N-SH and SH-SY5Y, as models of neuronal development. Each cell line can undergo active neuronal division and neurite outgrowth in response to IGFs 12'21'26'27'28. Similar phenotypic changes occur in vivo in developing neurons, leading us to speculate that these neuroblastoma cells would express fetal IGF transcripts.
Using RNase protection assays, we detected IGF II mRNA in SH-SY5Y cells and, in concurrence with Yee and colleagues 37, in SK-N-SH cells. Northern analysis of both cell types revealed three IGF II mRNA transcripts: 6.0 kb, 4.8 kb and 1.8 kb. The predominant IGF II mRNA in both cell lines was the 6.0 kb transcript, the major IGF II species in human fetal tissues 5'6. High levels of the 6.0 kb IGF II transcript in both neuroblastoma cell lines therefore mimics human fetal development.
In adult human, a sharp decline in total IGF 1I mRNA transcript levels coincides with the increased presence of the 4.8 kb IGF II transcript 5'6'33. Correspondingly, we found low levels of the 4.8 kb mRNA, presumably under the control of the P4 promoter, in actively growing SK-N-SH and SH-SY5Y cells. The third transcript, the 1.8 kb IGF II mRNA, was present in low amounts in both SK-N-SH and SH-SY5Y cells. While the exact significance of this transcript remains unclear, increasing evidence suggests it is the cleavage product of larger IGF lI mRNAs and functions to regulate total IGF II mRNA levels 3-~.
Little is known about the potential developmental regulation of type I and II IGF receptor gene expression. The type I IGF receptor is a membrane glycoprotein with four subunits connected by disulfide bonds to give a/3-a-~-/3 tetramer. IGF I binds to the a subunits and stimulates autophosphorylation of the /3 subunits via a tyrosine-specific protein kinase is. In multiple tissues, IGF I cDNA hybridization reveals an 11 kb and/or a 7 kb transcript 36. We detected the 11 kb type 1 IGF receptor transcript in both actively growing neuroblastoma cell lines, in agreement with previous RNase protection assays 22'37. Competitive binding and RNase protection assays indicate increased type I IGF receptor binding and mRNA levels after differentiation of SH-SY5Y cells 22, however, the potential changes in type I IGF receptor transcript species are unknown. Interestingly, when mouse 3T3-L1 fibroblasts are differentiated into adipocytes, there is a reduction of the type I IGF receptor 11 kb transcript 36.
Unlike the type I IGF receptor, the type II IGF receptor is a single polypeptide with no intrinsic tyrosine kinase activity. The type II IGF receptor is identical to the mannose-6-phosphate receptor 19, which mediates intracellular trafficking of lysosomal enzymes 4. The physiological significance of one receptor with distinct 2 but cooperative bindings sites for IGF II and mannose-6-phosphate z9 is unknown. Recent work, however, suggests that the type II IGF receptor may serve to integrate distinct growth-promoting signals from IGF II and mannose-6-phosphate 7 or secreted mannose-6-phosphate containing proteins, including cathepsin D t7, proliferin ~4 and transforming growth factor-/31 precursor 25. The presence of type II IGF receptor mRNA has not been previously reported in neuroblastoma cell lines. We detected a 9.4 kb transcript in actively growing SH-SY5Y and SK-N-SH cells, the same size as the type II IGF receptor transcript in human placenta 2°. There is little information on the potential regulation of type II IGF receptor gene expression with development, although competitive binding studies with iodinated-IGFs indicate changes in IGF receptor subtypes during fetal maturation 32.
We were unable to detect IGF I mRNA in either SK-N-SH or SH-SY5Y cells, in agreement with Yee and colleagues 37. We believe this increases the utility of these two cell lines as models of neuronal development. The lack of IGF I gene expression will allow us to examine the effects of 1GF II on neuronal growth and differentiation separately from IGF I.
Examined collectively, the presence of (1) abundant 6.0 kb IGF II mRNA with low abundance of 4.8 and 1.8 kb IGF II mRNAs, and (2) abundant 11.0 kb type I and 9.4 kb type II IGF receptor mRNA in dividing SK-N-SH and SH-SY5Y cells supports our contention that these cell lines are useful for understanding the differential regulation of IGF and IGF receptor mRNA during neuronal development. As an initial step toward determining the role of IGFs in neuronal ontogeny, we have begun examining changes in IGF II gene expression in differentiated neuroblastoma cell lines ~5.
